File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Emergence of Integrase Resistance Mutations during Initial Therapy Containing Dolutegravir

TitleEmergence of Integrase Resistance Mutations during Initial Therapy Containing Dolutegravir
Authors
Fulcher, Jennifer A.Du, YushenZhang, Tian HaoSun, RenLandovitz, Raphael J.
Keywordsantiretroviral therapy
integrase strand transfer inhibitors.
drug resistance
Issue Date2018
Citation
Clinical Infectious Diseases, 2018, v. 67, n. 5, p. 791-794 How to Cite?
DOI: http://dx.doi.org/10.1093/cid/ciy228
Abstract© The Author(s) 2018. Dolutegravir (DTG) is a preferred drug for initial treatment of human immunodeficiency virus type 1 infection. We present next-generation sequencing analysis of integrase genotypes during a period of virologic failure in a treatment-naive manwho initiated tenofovir disoproxil fumarate/emtricitabine plus DTG.
Persistent Identifierhttp://hdl.handle.net/10722/285818
ISSN
1058-4838
2021 Impact Factor: 20.999
2020 SCImago Journal Rankings: 3.440
PubMed Central ID
PMC6093998
ISI Accession Number ID
WOS:000442284400019

 

DC FieldValueLanguage
dc.contributor.authorFulcher, Jennifer A.-
dc.contributor.authorDu, Yushen-
dc.contributor.authorZhang, Tian Hao-
dc.contributor.authorSun, Ren-
dc.contributor.authorLandovitz, Raphael J.-
dc.date.accessioned2020-08-18T04:56:43Z-
dc.date.available2020-08-18T04:56:43Z-
dc.date.issued2018-
dc.identifier.citationClinical Infectious Diseases, 2018, v. 67, n. 5, p. 791-794-
dc.identifier.issn1058-4838-
dc.identifier.urihttp://hdl.handle.net/10722/285818-
dc.description.abstract© The Author(s) 2018. Dolutegravir (DTG) is a preferred drug for initial treatment of human immunodeficiency virus type 1 infection. We present next-generation sequencing analysis of integrase genotypes during a period of virologic failure in a treatment-naive manwho initiated tenofovir disoproxil fumarate/emtricitabine plus DTG.-
dc.languageeng-
dc.relation.ispartofClinical Infectious Diseases-
dc.subjectantiretroviral therapy-
dc.subjectintegrase strand transfer inhibitors.-
dc.subjectdrug resistance-
dc.titleEmergence of Integrase Resistance Mutations during Initial Therapy Containing Dolutegravir-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/cid/ciy228-
dc.identifier.pmid29933437-
dc.identifier.pmcidPMC6093998-
dc.identifier.scopuseid_2-s2.0-85054953932-
dc.identifier.volume67-
dc.identifier.issue5-
dc.identifier.spage791-
dc.identifier.epage794-
dc.identifier.eissn1537-6591-
dc.identifier.isiWOS:000442284400019-
dc.identifier.issnl1058-4838-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats